Fortinet Inc vs NeoGenomics Inc. Common Stock — how do they compare? Fortinet Inc trades at $181.55 (market cap $135.04B), while NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.14B). The key difference: Fortinet Inc is far larger — about 63.1× NeoGenomics Inc. Common Stock's market cap, and Fortinet Inc is trading nearer its 52-week high, NeoGenomics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fortinet Inc for 72 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| FTNT | NEO | |
|---|---|---|
Market Cap | $135.04B | $2.14B |
Volume | 3,955,126 | 2,228,400 |
Sector | Technology | Health |
52-Week High | $194.75 | $19.91 |
52-Week Low | $75.23 | $7.19 |
Typical Hold Time | 72 Days | 0 Days |
Enterprise Value | $131.47B | $2.44B |
Signals from Pluang's Aura AI — not financial advice
Fortinet (FTNT) trades at $190.76, down 1.13% on the day but remains in a bullish technical trend with strong support near $191. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $0.90 surpassing the $0.746 estimate. Revenue growth is steady, reaching $6.80B in 2025, while profitability metrics like a 28.17% net income margin and 117.44% ROE highlight operational efficiency. Recent news highlights AI-driven cybersecurity demand and a 52-week high, reflecting positive momentum.
The outlook for FTNT is positive, driven by cybersecurity tailwinds and superior product economics, but high valuation ratios (P/E of 67.41, P/S of 18.95) pose risks if growth slows. Analyst consensus is mixed with 42% buy ratings, and the stock trades above the $160.24 price target, suggesting limited near-term upside. Key risks include competitive pressures and execution challenges in sustaining high growth rates.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Fortinet is a cybersecurity vendor that sells products, support, and services to small and midsize businesses, enterprises, and government entities. Its products include unified threat management appliances, firewalls, network security, and its security platform, Security Fabric. Services revenue is primarily from FortiGuard security subscriptions and FortiCare technical support. At the end of 2021, products were 38% of revenue and services were 62% of sales. The California-based company sells products worldwide.
Read more on FTNT →NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →